115
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Association of PON1, TNF-α and TGF-β gene polymorphisms with prognosis in oral and oropharyngeal squamous cell carcinoma

ORCID Icon, , , , , , , & show all
Pages 327-334 | Received 26 May 2020, Accepted 04 Nov 2020, Published online: 15 Feb 2021

References

  • Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013;63(1):12–25.
  • Domingos PAS, Passalacqua MLC, Oliveira ALBM. Câncer Bucal: um problema de Saúde pública. Rev Odontol Univ Cid São Paulo. 2014;26(1):46–52.
  • Lemos CAL, Jr, Alves FA, Torres-Pereira CC, et al. Câncer de boca baseado em evidências científicas. Rev Assoc Paul Cir Dente. 2013;67(3):178–186.
  • Song Y, Miao Y, Song CP. Behind the scenes: the roles of reactive oxygen species in guard cells. New Phytol. 2014;201(4):1121–1140.
  • Bacchetti T, Ferretti G, Sahebkar A. The role of paraoxonase in cancer. Semin Cancer Biol. 2019;56:72–86.
  • Malik UU, Siddiqui IA, Hashim Z, et al. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clin Chim Acta. 2014;430:38–42.
  • Stockmann C, Schadendorf D, Klose R, et al. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.
  • Erdei E, Luo L, Sheng H, et al. Cytokines and tumor metastasis gene variants in oral cancer and precancer in Puerto Rico. PLoS One. 2013;8(11):e79187.
  • Luersen K, Schmelzer C, Boesch-Saadatmandi C, et al. Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males. BMC Res Notes. 2011;4:141.
  • Sterling JA, Wu L, Banerji SS. PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines. Anticancer Res. 2006;26(3A):1893–1901.
  • Fang DH, Fan CH, Ji Q, et al. Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies. Mol Biol Rep. 2012; 39(6):6801–6809.
  • Jin L, Sturgis EM, Zhang Y, et al. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma. Mol Cancer. 2013;12:80.
  • Singh PK, Bogra J, Chandra G, et al. Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population. Cancer Biomark. 2015;15(2):125–131.
  • Chen G, Hu C, Lai P, et al. Association between TGF-β1 rs1982073/rs1800469 polymorphism and lung cancer susceptibility: an updated meta-analysis involving 7698 cases and controls. Medicine (Baltimore). 2019;98(47):e18028.
  • Patel SM, Koringa PG, Reddy BB, et al. In silico analysis of consequences of non-synonymous SNPs of Slc11a2 gene in Indian bovines. Genom Data. 2015;5:72–79.
  • Kieszko R, Krawczyk P, Chocholska S, et al. TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(2):131–137.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
  • Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma – an update. CA Cancer J Clin. 2015;65(5):401–421.
  • Luo YQ, Wang D, Gong T, et al. An updated meta-analysis of 37 case-control studies on the association between NFKB1-94ins/del ATTG promoter polymorphism and cancer susceptibility. Oncotarget. 2016;7(36):58659–58670.
  • Mesquita D, Jr, Araújo JAP, Catelan TTT, et al. Immune system – part II basis of the immunological response mediated by T and B lymphocytes. Bras J Rheumatol. 2010;50(5):552–580.
  • Cruvinel WM, Mesquisa D, Jr, Araújo JAP, et al. Immune system –part I fundamentals of innate immunity with emphasis on molecular and cellular mechanisms of inflammatory response. Bras J Rheumatol. 2010;50(4):434–461.
  • Fabregat I, Fernando J, Mainez J, et al. TGF-beta signaling in cancer treatment. Curr Pharm Des. 2014;20(17):2934–2947.
  • Hsu HJ, Yang YH, Shieh TY, et al. TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese. Kaohsiung J Med Sci. 2015;31(3):123–129.
  • Geng R, Chen Z, Zhao X, et al. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy. PLoS One. 2014;9(12):e116027.
  • Tang W, Liu J, Wang Y, et al. Association between Paraoxonase 1 polymorphisms and risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 subjects. Oncotarget. 2017;8(60):101095–101102.
  • Kahraman FU, Torun E, Osmanoğlu NK, et al. Serum oxidative stress parameters and paraoxonase-1 in children and adolescents exposed to passive smoking. Pediatr Int. 2017;59(1):68–73.
  • Eom SY, Yim DH, Lee CH, et al. Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population. PLoS One. 2015;10(3):e0119100.
  • Wen Y, Huang Z, Zhang X, et al. Correlation between PON1 gene polymorphisms and breast cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8(11):20343–20348.
  • Lurie G, Wilkens LR, Thompson PJ, et al. Genetic polymorphisms in the paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2070–2077.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.